Apr 28, 2026

Email 1 Summary:

– COVID-19’s impact six years later is less severe but still evolving; new strains might overcome immunity but cause milder illness.

– GLP-1 weight loss drugs may increase risk of eating disorders; physicians need to screen patients carefully.

– NIH-funded research seldom analyzes data by sex, affecting applicability across genders.

– Innovation covers new brain stimulation tech for depression and ethical concerns about patient control in private mental health.

– Additional news includes psychedelics FDA priority review and an AI pilot for prescriptions halted in Utah.

Email 2 Summary:

– Long-term care hospitals closing rapidly, causing hospital bed shortages and stressing health systems.

– Medicare policies limit payments to long-term care hospitals, causing financial strain and debate over cost-effectiveness.

– Major insurers are standardizing pre-treatment review processes to reduce delays and denials.

– Protests by health activists over pesticide (Roundup) lawsuits as Trump administration backs Bayer.

– Flu vaccine coverage remains low among nursing home healthcare workers; new CDC data highlights gaps.

Email 3 Summary:

– Trump administration fired entire US NSF science advisory board without explanation, continuing pattern of undermining science advice.

– Study reveals online sale of fake research authorships costing $57 to over $5,600, exposing academic fraud risks.

– A mysterious “golden orb” from deep sea is confirmed as dead cells from a new deep-sea anemone species.

– Calls for grant funding systems to adapt due to AI-generated grant proposals increasing in volume and quality.

– Nature announces photo contest #ScientistAtWork 2026 and features book on evidence-based science decision-making.

Stay Well!